GIST has activating mutations in the KIT or platelet-derived growth factor receptor alpha (PDGFRa) gene, which act as the main oncogenic drivers [1–3] and are harbored by 75–80% and approximately 10% of tumors, respectively. This evidence concerns the gene KIT and gastrointestinal stromal tumor.